BIOCOM for BIOCOM
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Supported the reauthorization of PAHPA Expressed concerns with step therapy policy, changes to Medicare Part B, and changes to the Part D protected classes Expressed support for banning "gag clauses" in contract with pharmacists Discussed how the life science community can help address the opioid crisis Advocated for reforms of the 340B drug program
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Co-hosted a congressional briefing on the importance of intellectual property to advance global health Advocated for reforms of IPR proceedings at the PTAB, including support of the STRONGER Patents Act Expressed support for the agencys proposed rule Changes to the Claim Construction Standard for Interpreting Claims in Trial Proceedings Before the Patent Trial and Appeal Board"
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Energy/Nuclear ENG
Supported mandatory funding for the Energy Title in the Farm Bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Taxation/Internal Revenue Code TAX
Advocated for the suspension of the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Budget/Appropriations BUD
Advocated for increased funding for NIH and FDA in FY2019 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.